BioStock: Respiratorius continues to strengthen VAL001

Last winter, Respiratorius presented positive results from the pharmacokinetic study with the new formulation of VAL001. The company has now announced that it has filed a new patent application regarding the formulation, which further strengthens the protection for the candidate. At the same time, work continues to build a strong case in the partnering process that is currently underway.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/07/respiratorius-fortsatter-att-starka-val001/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se